Laura Towart: We are uniquely positioned to model complex cancers for therapeutics discovery

Laura Towart, Founder and CEO at Vivan Therapeutics, shared on LinkedIn:

“Thank you to Alice Gast and the Financial Times for highlighting the lack of funding and therefore advances in rare cancer treatment. We at Vivan Therapeutics are uniquely positioned to model complex cancers including rare cancers using our personalized in vivo platform for therapeutics discovery.

Ross Cagan and Marshall Posner have made great strides towards rare head and neck cancer therapeutics and we have been continuing this effort for other cancers. We launched the My Personal Therapeutics Foundation charity to campaign for funding support to advance our discoveries and to support patient treatment journeys.”

For more details click here.
Source: Laura Towart/LinkedIn